243 related articles for article (PubMed ID: 6358352)
21. Discordance between transferrin receptor expression and susceptibility to lysis by natural killer cells.
Bridges KR; Smith BR
J Clin Invest; 1985 Sep; 76(3):913-8. PubMed ID: 2995450
[TBL] [Abstract][Full Text] [Related]
22. The low affinity 40,000 Fc gamma receptor and the transferrin receptor can be alternative or simultaneous target structures on cells sensitive for natural killing.
Perl A; Looney RJ; Ryan DH; Abraham GN
J Immunol; 1986 Jun; 136(12):4714-20. PubMed ID: 3011902
[TBL] [Abstract][Full Text] [Related]
23. Anti-idiotype antibodies to the 9.1C3 blocking antibody used to probe the lethal hit stage of NK cell-mediated cytolysis.
Werkmeister JA; Burns GF; Triglia T
J Immunol; 1984 Sep; 133(3):1385-90. PubMed ID: 6611373
[TBL] [Abstract][Full Text] [Related]
24. Mechanism of cell-mediated cytotoxicity at the single cell level. VI. Direct assessment of the cytotoxic potential of human peripheral blood non-lytic effector-target cell conjugates.
Bonavida B; Lebow LT; Bradley TP
J Immunol; 1984 Feb; 132(2):594-8. PubMed ID: 6606675
[TBL] [Abstract][Full Text] [Related]
25. Mechanism of cell contact-mediated inhibition of natural killer activity.
Heiskala MK; Carpén O; Saksela E; Timonen T
J Immunol; 1987 Sep; 139(5):1414-8. PubMed ID: 3624862
[TBL] [Abstract][Full Text] [Related]
26. Lysis of natural killer-sensitive and -resistant tumor cells by natural killer cytotoxic factors (NKCF)-containing liposomes.
Roozemond RC; Urli DC; Wright SC; Graves SS; Bonavida B
Immunobiology; 1987 Dec; 176(1-2):35-46. PubMed ID: 3447981
[TBL] [Abstract][Full Text] [Related]
27. Effects of X-ray irradiation on natural killer (NK) cell system. II. Increased sensitivity to natural killer cytotoxic factor (NKCF).
Uchida A; Mizutani Y; Nagamuta M; Ikenaga M
Immunopharmacol Immunotoxicol; 1989; 11(2-3):521-34. PubMed ID: 2621326
[TBL] [Abstract][Full Text] [Related]
28. An exoglycosidase-sensitive triggering site on NK cells which is coupled to transmethylation of membrane phospholipids.
Kiyohara T; Dennis JW; Boegman RJ; Roder JC
J Immunol; 1985 Jul; 135(1):659-64. PubMed ID: 3923114
[TBL] [Abstract][Full Text] [Related]
29. Analysis of cytostatic/cytotoxic lymphokines: relationship of natural killer cytotoxic factor to recombinant lymphotoxin, recombinant tumor necrosis factor, and leukoregulin.
Ortaldo JR; Ransom JR; Sayers TJ; Herberman RB
J Immunol; 1986 Nov; 137(9):2857-63. PubMed ID: 3093586
[TBL] [Abstract][Full Text] [Related]
30. Evidence for an early calcium-independent event in the activation of the human natural killer cell cytolytic mechanism.
Brahmi Z; Bray RA; Abrams SI
J Immunol; 1985 Dec; 135(6):4108-13. PubMed ID: 3864859
[TBL] [Abstract][Full Text] [Related]
31. Characterization of the cytolytic reaction mechanism of the human natural killer (NK) lymphocyte: resolution into binding, programming, and killer cell-independent steps.
Hiserodt JC; Britvan LJ; Targan SR
J Immunol; 1982 Oct; 129(4):1782-7. PubMed ID: 6180023
[TBL] [Abstract][Full Text] [Related]
32. Mechanism of norepinephrine-mediated inhibition of human NK cytotoxic functions: inhibition of cytokine secretion, target binding, and programming for cytotoxicity.
Gan X; Zhang L; Solomon GF; Bonavida B
Brain Behav Immun; 2002 Jun; 16(3):227-46. PubMed ID: 12009684
[TBL] [Abstract][Full Text] [Related]
33. A novel antigenic cell surface protein associated with T200 is involved in the post-activation stage of human NK cell-mediated lysis.
Burns GF; Werkmeister JA; Triglia T
J Immunol; 1984 Sep; 133(3):1391-6. PubMed ID: 6379048
[TBL] [Abstract][Full Text] [Related]
34. Studies on the mechanism of natural killer cell-mediated cytotoxicity. VI. Characterization of human, rat, and murine natural killer cytotoxic factors.
Wright SC; Wilbur SM; Bonavida B
Nat Immun Cell Growth Regul; 1985; 4(4):202-20. PubMed ID: 2999581
[TBL] [Abstract][Full Text] [Related]
35. Potassium channels in human NK cells are involved in discrete stages of the killing process.
Sidell N; Schlichter LC; Wright SC; Hagiwara S; Golub SH
J Immunol; 1986 Sep; 137(5):1650-8. PubMed ID: 2427578
[TBL] [Abstract][Full Text] [Related]
36. Antileukemia activity of a natural killer cell line against human leukemias.
Yan Y; Steinherz P; Klingemann HG; Dennig D; Childs BH; McGuirk J; O'Reilly RJ
Clin Cancer Res; 1998 Nov; 4(11):2859-68. PubMed ID: 9829753
[TBL] [Abstract][Full Text] [Related]
37. Definition of a "trigger" stage in the NK cytolytic reaction sequence by a monoclonal antibody to the glycoprotein T-200.
Targan SR; Newman W
J Immunol; 1983 Sep; 131(3):1149-53. PubMed ID: 6886418
[TBL] [Abstract][Full Text] [Related]
38. Relation of natural killer cell line NK-92-mediated cytolysis (NK-92-lysis) with the surface markers of major histocompatibility complex class I antigens, adhesion molecules, and Fas of target cells.
Komatsu F; Kajiwara M
Oncol Res; 1998; 10(10):483-9. PubMed ID: 10338151
[TBL] [Abstract][Full Text] [Related]
39. VLA-6 (CDw49f) is an important adhesion molecule in NK cell-mediated cytotoxicity following autologous or allogeneic bone marrow transplantation.
Lowdell MW; Shamim F; Hamon M; Macdonald ID; Prentice HG
Exp Hematol; 1995 Dec; 23(14):1530-4. PubMed ID: 8542943
[TBL] [Abstract][Full Text] [Related]
40. NK recognition of target structures: is the transferrin receptor the NK target structure?
Newman RA; Warner JF; Dennert G
J Immunol; 1984 Oct; 133(4):1841-5. PubMed ID: 6206139
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]